HIV Neutralizing Antibody Titer During Structured Treatment Interruption of Highly Active Antiretroviral Therapy

AIDS - United States
doi 10.1097/qad.0b013e3283550b47
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cognitive Functioning During Highly Active Antiretroviral Therapy Interruption in Human Immunodeficiency Virus Type 1 Infection

Journal of NeuroVirology
VirologyNeurologyCellularMolecular Neuroscience
2008English

Longitudinal Bioluminescent Imaging of HIV-1 Infection During Antiretroviral Therapy and Treatment Interruption in Humanized Mice

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2019English

Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity

Scandinavian Journal of Immunology
MedicineImmunology
2001English

Patients' Readiness to Start Highly Active Antiretroviral Treatment for HIV

BMJ
2005English

Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function

JAMA Otolaryngology - Head and Neck Surgery
MedicineOtorhinolaryngologySurgery
2015English

Using Highly Active Antiretroviral Therapy to Decrease Perioperative HIV-1 Transmission Risk

AIDS
Infectious DiseasesAllergyImmunology
2010English

Pregnancy Outcomes in Booked HIV Positive Women Initiating Highly Active Antiretroviral Therapy

Journal of Medical and Biomedical Sciences
2014English

Recurrent Pulmonary Sarcoidosis in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Highly Active Antiretroviral Therapy and Survival in HIV-Infected Injection Drug Users

JAMA - Journal of the American Medical Association
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy